News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
93 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (21247)
Month
January (2433)
February (2866)
March (3029)
April (3115)
May (3356)
June (2725)
July (2286)
August (1437)
Day
2 (21)
3 (134)
4 (182)
5 (180)
6 (174)
7 (76)
9 (47)
10 (146)
11 (152)
12 (93)
13 (140)
14 (92)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
Day
2
3
4
5
6
7
9
10
11
12
13
14
Earnings
BridgeBio continues ATTR ascent as Alnylam’s Amvuttra falls short of expectations
BridgeBio Pharma’s transthyretin amyloidosis medicine Attruby is off to a strong launch, while Alnylam lowered full-year sales guidance for competitor Amvuttra.
August 12, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
·
15 min read
Press Releases
Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
August 12, 2026
·
9 min read
Press Releases
Kamada Reports Record-High First Half and Second Quarter 2026 Financial Results, Representing Double-Digit Profitable Growth and the Strongest in Kamada’s History; Affirms 2026 Annual Guidance
August 12, 2026
·
21 min read
Press Releases
TScan Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
·
11 min read
Press Releases
Kamada Announces Planned Transition of Chief Financial Officer
August 12, 2026
·
3 min read
Press Releases
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
August 12, 2026
·
13 min read
Press Releases
Lexeo Therapeutics Reports Second Quarter 2026 Financial Results and Operational Highlights
August 12, 2026
·
8 min read
Press Releases
Humacyte Announces Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
·
21 min read
Press Releases
Attralus Has Been Granted U.S. FDA Fast Track Designation for Zamubafusp Alfa (AT-02) for the Treatment of AL Amyloidosis
August 12, 2026
·
5 min read
Previous
3 of 10
Next
